May 24, 2018 – Global executive search firm Coulter Partners recently made eight new appointments in the U.S., Denmark and at their London headquarters.
In the U.S., Noah Parekh joins as client partner in Cambridge, MA, while Lisa Pieper has been appointed consulting partner in Palo Alto, CA, and Adrienne Slutzky joins as project coordinator in Short Hills, NJ. In London, new team additions include Quentin Oerlemans as senior consultant, Pat Mileham as senior production associate, and Agata Grzeszczuk and Kerry Hillier as production associates. In Copenhagen, Charlotte Visholm joins as production associate.
“We are delighted to attract the most exceptional talent to our team across the globe and welcome all new colleagues with their diverse expertise and specialist knowledge,” said Bianca Coulter, CEO. “A thriving life sciences industry has driven this further growth at Coulter Partners, and we will continue to respond to market need by consolidating our team in key industry hubs.”
Mr. Parekh joins as lead on C-suite, board and senior level global executive search assignments across the scientific and commercial spectrum in the pharmaceutical and biotechnology sectors. He draws on over 16 years of experience in life science search, most recently as partner with Chase Search Group, the retained search firm he founded in 2006 in Cambridge, MA. With 20 years in executive search, Mr. Parekh brings extensive expertise at senior director, VP and CMO-suite within operations, clinical research, regulatory affairs, medical affairs and biometrics.
|Check out our latest upload from Coulter Partners|
Ms. Pieper will lead organizational and leadership advisory services, with an emphasis on strategy and corporate development. She has spent almost two decades building teams and organizations in life sciences, which included a decade as a consultant in the life sciences practices of global executive search firms including Spencer Stuart and Korn Ferry. She founded a life sciences consulting firm, Pieper & Associates, with services that included executive-level and board recruitment. Ms. Pieper previously practiced medicine for a decade in a large multi-specialty group practice, serving in a variety of leadership roles. A fellow at Stanford University’s Distinguished Careers Institute, she has also served for over a decade on the president’s council of the Gladstone Institutes, a non-profit biomedical research foundation based in San Francisco.
Mr. Oerlemans will focus on board and C-suite global executive search for pharmaceutical, digital health, biotechnology and medical device companies, advising at all stages of growth, from venture-backed and development to established and publicly-held corporations. He draws on more than 12 years’ executive search experience with global search firms including Egon Zehnder and most recently with a start-up specializing in VC backed and PE businesses. His track record in global executive search, both for life sciences and the technology sector, includes a prior three-year tenure with Coulter Partners and encompasses leadership assessment, family business and CEO succession advisory, across geographies that include APAC and LATAM.
Dr. Mileham will be responsible for research and execution of senior-level global executive search assignments with a broad life science focus and an emphasis on scientific and technical roles in the pharma and biotech sectors. He has six years of search experience as team/practice leader, and then operations director for an international specialist life science search firm. Dr. Mileham previously worked as a researcher for a collaboration between Big Pharma, the biochemistry department at St. Mary’s Hospital Medical School and the pathology department of the Royal London Hospital.
Ms. Grzeszczuk will engage in senior-level global executive search with a broad life science focus across scientific, technical and commercial roles. She has over 11 years of executive search experience predominantly in life sciences but also in FMCG, gained with leading international recruitment consultancies. Ms. Grzeszczuk brings broad experience not only in executive search, but also in in-house talent acquisition, global transformation projects and coaching.
Ms. Hillier will execute senior-level international executive search assignments with a broad life science focus, encompassing both scientific and commercial roles. She has three years of experience in multiple sector recruitment gained with Miramar Global Executive Search and Gerard Daniels working across EMEA, APAC and the Americas. Ms. Hillier brings prior experience in project management and research, working for Imperial College in London in infectious diseases and immunology and previously for an international engineering company.
Ms. Visholm will work on senior-level international executive search assignments with a broad focus across both scientific and commercial roles. She draws on 19 years’ experience in multiple sector recruitment gained with global executive search firms including Odgers Berndtson and brings an extensive track record of international private and public sector, board and C-suite executive search.
Ms. Slutzky will be responsible for project management and execution of global search assignments, and business development support to the team across the U.S. She brings strong relationship management and organizational skills gained over four years as senior operations associate for the Stevenson Group, a retained executive search firm with a life science emphasis. She draws on additional administrative experience within a data-intensive marketing and advertising technology company.
Life Sciences Specialists
Coulter Partners is a senior-level executive search boutique focused exclusively on identifying global life sciences leaders and board directors. The firm serves clients in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors.
Tapping Outside Talent for Life Science and Healthcare
For these top 50 executive recruiters working in the life science and healthcare sectors, the last decade has been one of transformation. Pressure on pricing, regulatory changes, emerging innovations, growth, and an uncertain political environment have all helped shape a new field of play.
|Top 50 Ranking|
Coulter currently operates overseas offices in the U.K., Germany, Switzerland and Denmark. In the U.S., the firm has offices in Cambridge, MA; Princeton, NJ; Pittsburgh; Los Angeles; and Short Hills, NJ.
Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies for the foreseeable future, according to Deloitte’s global sector outlook on life sciences. Navigating this new world of work requires a dramatic change in strategies for leadership, talent and human resources. What’s more, the global life sciences sector in the midst of a turbulent transformation, making the need for innovative leaders more important than ever.
It’s no wonder why Coulter Partners continues its aggressive expansion. This past year the firm made seven new appointments in the U.S., Switzerland, Germany and at its London headquarters. Joining the firm were Nona Footz, client partner; Samantha Simonnet, director on the U.S. West Coast; Jean Kim, associate director in New York; and Marie-Garance Leroy, senior consultant in Zurich. Also, Samantha Ng was appointed senior production associate in London; Patrick Williams was named production associate in Boston; and Jodie Gadd joined the Frankfurt team as research associate.
In addition, Coulter Partners opened an office in Zurich and tapped Phillipp Buis to serve as executive director. Mr. Buis focuses on senior-level international search work across a broad spectrum of scientific and commercial functions in the pharmaceuticals, med tech and biotech sectors, with an emphasis on discovery, global clinical development and medical affairs. He heads the Zurich office and draws on an extensive track record gained over 18 years in executive search, partnering with leading niche players as well as large cap corporations within life sciences.
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Will Schatz, Managing Editor – Hunt Scanlon Media